{
  "id": "CG-EX:EvLn121",
  "type": "EvidenceLine",
  "evidenceItem": [
    {
      "id": "CG-EX:CritAssess361",
      "type": "CriterionAssessment",
      "criterion": {
        "id": "SEPIO-CG:99022",
        "type": "Criterion",
        "label": "PVS1",
        "description": "null variant (nonsense, frameshift, canonical Â±1 or 2 splice sites, initiation codon, single or multiexon deletion) in a gene where LOF is a known mechanism of disease",
        "defaultStrength": {
          "id": "SEPIO:0000220",
          "type": "EvidenceLineStrength",
          "label": "Pathogenic Very Strong"
        },
        "comments": "The two main concerns for applying this rule is:\na. Is LOF an established disease mechanism?\nb. Is LOF actually occurring?"
      },
      "variant": {
        "id": "CAR:CA022880",
        "type": "CanonicalAllele",
        "preferredCtxAllele": {
          "id": "CG-EX:CtxAll127",
          "type": "ContextualAllele",
          "relatedCanonicalAllele": "CanAll121",
          "alleleName": "NM_024422.3(DSC2): c.631-2A>G (p.?)"
        }
      },
      "condition": [
        {
          "id": "CG-EX:GenCond046",
          "type": "GeneticCondition",
          "disease": [
            {
              "id": "Orphanet:247",
              "type": "Disease",
              "label": "arrhythmogenic right ventricular cardiomyopathy"
            }
          ]
        }
      ],
      "outcome": {
        "id": "SEPIO:0000223",
        "type": "CriterionEvaluation",
        "label": "Met"
      },
      "evidenceLine": [
        {
          "id": "CG-EX:EvLn103",
          "type": "EvidenceLine",
          "evidenceItem": [
            {
              "id": "CG-EX:MolCon272",
              "type": "AlleleMolecularConsequence",
              "contextualAllele": {
                "id": "CG-EX:CtxAll127",
                "type": "ContextualAllele",
                "relatedCanonicalAllele": "CanAll121",
                "alleleName": "NM_024422.3(DSC2): c.631-2A>G (p.?)"
              },
              "consequence": {
                "id": "SO:0001629",
                "type": "MolecularConsequence",
                "label": "splice-site variant"
              },
              "description": "This variant occurs in the invariant region (+/- 1,2) of the splice consensus sequence and in vitro studies confirmed that it leads to aberrant splicing and reduced DSC2 protein levels (Heuser 2006 PMID: 17186466)."
            },
            {
              "id": "CG-EX:CondMech273",
              "type": "ConditionMechanism",
              "mechanism": {
                "id": "SO:0002054",
                "type": "Mechanism",
                "label": "loss of function variant"
              },
              "condition": {
                "id": "CG-EX:GenCond046",
                "type": "GeneticCondition",
                "disease": [
                  {
                    "id": "Orphanet:247",
                    "type": "Disease",
                    "label": "arrhythmogenic right ventricular cardiomyopathy"
                  }
                ]
              },
              "mechanismConfidence": {
                "id": "SEPIO:0000269",
                "type": "ConditionMechanismStrength",
                "label": "established"
              },
              "gene": {
                "id": "HGNC:3036",
                "type": "Gene",
                "geneSymbol": "DSC2"
              },
              "description": "Splice and other loss-of-function variants in DSC2 have been reported in individuals with ARVC (http://arvcdatabase.info/)."
            }
          ]
        }
      ],
      "contribution": [
        {
          "type": "Contribution",
          "agent": {
            "id": "CG-EX:Agent007",
            "type": "Agent",
            "label": "Stefan DiMarino"
          },
          "contributionDate": "01/17/17 9:12 AM",
          "contributionRole": {
            "id": "SEPIO:0000154",
            "type": "ContributoryRole",
            "label": "assessor role"
          }
        }
      ],
      "description": "This variant occurs in the invariant region (+/- 1,2) of the splice consensus sequence and in vitro studies confirmed that it leads to aberrant splicing and reduced DSC2 protein levels (Heuser 2006 PMID: 17186466). Splice and other loss-of-function variants in DSC2 have been reported in individuals with ARVC (http://arvcdatabase.info/)."
    }
  ],
  "evidenceStrength": {
    "id": "SEPIO:0000220",
    "type": "EvidenceLineStrength",
    "label": "Pathogenic Very Strong"
  },
  "contribution": [
    {
      "type": "Contribution",
      "agent": {
        "id": "CG-EX:Agent007",
        "type": "Agent",
        "label": "Stefan DiMarino"
      },
      "contributionDate": "01/17/17 9:12 AM",
      "contributionRole": {
        "id": "SEPIO:0000154",
        "type": "ContributoryRole",
        "label": "assessor role"
      }
    }
  ],
  "@context": "http://datamodel.clinicalgenome.org/interpretation/json/context"
}
